Patents by Inventor Richard Epstein

Richard Epstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5834291
    Abstract: Inviable T4 phage-like particles capable of directing the expression of large non-T4 DNA fragments from T4 expression control sequences are produced. Thus, E. coli harboring pBR322 derivatives containing cloned T4 gene 23 DNA sequences were infected with T4 phage carrying a deletion of the denB gene. Homology-dependent recombination results in the production of inviable phage-like particles containing DNA molecules composed of multiple, tandemly repeated copies of entire plasmid molecules covalently linked to single copies of normal phage genes. The yield of these inviable particles, intially low, was increased by means of a reiterated infection process that involves the use of a cloned T4 origin of replication. When T4 gene 32 expression control sequences linked in proper orientation to a DNA sequence coding for the non-T4 protein .beta.-galactosidase were also cloned in one such pBR322 derivative (pVH773), inviable phage particles capable of directing the synthesis of enzymatically active .beta.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 10, 1998
    Inventors: Thomas Lee Mattson, Richard Epstein
  • Patent number: 5559018
    Abstract: Inviable T4 phage-like particles capable of directing the expression of large non-T4 DNA fragments from T4 expression control sequences are produced. Thus, E. coli harboring pBR322 derivatives containing cloned T4 gene 23 DNA sequences were infected with T4 phage carrying a deletion of the denB gene. Homology-dependent recombination results in the production of inviable phage-like particles containing DNA molecules composed of multiple, tandemly repeated copies of entire plasmid molecules covalently linked to single copies of normal phage genes. The yield of these inviable particles, intially low, was increased by means of a reiterated infection process that involves the use of a cloned T4 origin of replication. When T4 gene 32 expression control sequences linked in proper orientation to a DNA sequence coding for the non-T4 protein .beta.-galactosidase were also cloned in one such pBR322 derivative (pVH773), inviable phage particles capable of directing the synthesis of enzymatically active .beta.
    Type: Grant
    Filed: September 15, 1992
    Date of Patent: September 24, 1996
    Inventors: Thomas L. Mattson, Richard Epstein
  • Patent number: 4332011
    Abstract: A data processing arrangement including a microprocessor and a plurality of input/output devices arranged in groups in accordance with a predetermined priority scheme. Each input/output device is capable of initiating a service request via an interrupt line to the microprocessor as a result of which a machine cycle is initiated by the microprocessor in which control signals are produced by the microprocessor and applied to logic circuitry coupled to the groups of input/output devices. The logic circuitry operates to propagate a low voltage level at the output of the input/output device initiating the service request down through the lower priority groups and to change inputs of the lower priority input/output devices from normal high voltage levels to low voltage levels. Data is then applied by the input/output device initiating the service request to the microprocessor, following which a microprocessor reset instruction resets the device.
    Type: Grant
    Filed: March 17, 1980
    Date of Patent: May 25, 1982
    Assignee: Cambridge Telecommunications, Inc.
    Inventors: Richard A. Epstein, Henry A. Zannini